Bristol Myers Squibb Co. Stock Rises Wednesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.40% higher to $71.94 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.28% to 3,969.61 and the Dow Jones Industrial Average rising 0.80% to 33,973.01. This was the stock's second consecutive day of gains. Bristol Myers Squibb Co. closed $9.50 short of its 52-week high ($81.44), which the company achieved on December 1st.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.16% to $174.88, Pfizer Inc. (PFE) fell 0.36% to $47.45, and Abbott Laboratories (ABT) fell 0.61% to $113.15. Trading volume (7.3 M) remained 2.0 million below its 50-day average volume of 9.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 11, 2023.
(END) Dow Jones Newswires
January 11, 2023 16:42 ET (21:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.